Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 3/20 | 0.38 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.38 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | F2 | P00734 | 2/20 | 0.36 |
| ▸ | CTSL | P07711 | 1/20 | 0.36 |
| ▸ | CTSS | P25774 | 1/20 | 0.36 |
| ▸ | CTSK | P43235 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29498244 | 0.96 | DPP4 (0.40) | DPP4DPP8DPP9OPRM1F2 | |
| SCHEMBL31201041 | 0.84 | CTSL (0.41) | OPRM1F2CTSLCTSSCTSK | |
| SCHEMBL29568748 | 0.84 | APLNR (0.41) | OPRM1F2CTSLCTSSCTSK | |
| SCHEMBL10864928 | 0.83 | OPRM1 (0.43) | DPP4DPP8DPP9OPRM1 | |
| SCHEMBL4595209 | 0.83 | DPP4 (0.44) | DPP4DPP8DPP9F2 | |
| SCHEMBL5734357 | 0.83 | DPP4 (0.44) | DPP4DPP8DPP9F2 | |
| SCHEMBL4595206 | 0.83 | DPP4 (0.44) | DPP4DPP8DPP9F2 | |
| Bromide SCHEMBL10345828 | 0.82 | OPRM1 (0.42) | DPP4DPP8DPP9OPRM1 | |
| SCHEMBL29565378 | 0.82 | CTSL (0.40) | OPRM1F2CTSLCTSSCTSK | |
| SCHEMBL7271617 | 0.82 | NPSR1 (0.46) | DPP4DPP8DPP9OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12472245-B2 | Compositions and methods | CHAIN BIOTECHNOLOGY LIMITED (GB) | 2025-11-18 | — | — | US | disclosed |
| US-20250213673-A1 | COMPOSITIONS AND METHODS | CHAIN BIOTECHNOLOGY LIMITED (GB) | 2025-07-03 | — | — | US | disclosed |
| US-20240058433-A1 | COMPOSITIONS AND METHODS | CHAIN BIOTECHNOLOGY LTD (GB) | 2024-02-22 | — | — | US | disclosed |
| US-11833220-B2 | Artificial multi-antigen fusion protein and preparation and use thereof | OXFORD VACMEDIX UK LTD. (GB) | 2023-12-05 | — | — | US | disclosed |
| EP-4262861-A1 | COMPOSITIONS AND METHODS | Chain Biotechnology Limited (GB) | 2023-10-25 | — | — | EP | disclosed |
| WO-2022129881-A1 | COMPOSITIONS AND METHODS | CHAIN BIOTECHNOLOGY LIMITED (GB) | 2022-06-23 | — | — | WO | disclosed |
| EP-3971215-A2 | ARTIFICIAL MULTI-ANTIGEN FUSION PROTEIN AND PREPARATION AND USE THEREOF | Oxford Vacmedix UK Ltd. (GB) | 2022-03-23 | — | — | EP | disclosed |